Zions Bancorporation N.A. Has $5.69 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Zions Bancorporation N.A. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,577 shares of the medical equipment provider’s stock after acquiring an additional 621 shares during the period. Zions Bancorporation N.A.’s holdings in Intuitive Surgical were worth $5,687,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. KBC Group NV increased its position in shares of Intuitive Surgical by 65.6% during the third quarter. KBC Group NV now owns 424,739 shares of the medical equipment provider’s stock worth $208,661,000 after acquiring an additional 168,210 shares in the last quarter. Huntington National Bank increased its position in shares of Intuitive Surgical by 4.1% during the third quarter. Huntington National Bank now owns 277,377 shares of the medical equipment provider’s stock worth $136,267,000 after acquiring an additional 10,806 shares in the last quarter. Bouvel Investment Partners LLC increased its position in shares of Intuitive Surgical by 0.5% during the third quarter. Bouvel Investment Partners LLC now owns 13,950 shares of the medical equipment provider’s stock worth $6,853,000 after acquiring an additional 67 shares in the last quarter. Schrum Private Wealth Management LLC grew its position in Intuitive Surgical by 6.6% in the 3rd quarter. Schrum Private Wealth Management LLC now owns 2,738 shares of the medical equipment provider’s stock worth $1,345,000 after purchasing an additional 169 shares in the last quarter. Finally, ICICI Prudential Asset Management Co Ltd grew its position in Intuitive Surgical by 19.0% in the 3rd quarter. ICICI Prudential Asset Management Co Ltd now owns 4,638 shares of the medical equipment provider’s stock worth $2,279,000 after purchasing an additional 742 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ISRG shares. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 91,178 shares of company stock valued at $45,897,071. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $536.69 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $287.98 and a fifty-two week high of $542.59. The firm’s fifty day moving average price is $496.95 and its 200-day moving average price is $455.65. The stock has a market cap of $191.16 billion, a P/E ratio of 86.28, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.